Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2013

View Archived Issues

Ghrelin agonist tested in gastrointestinal symptoms related to Parkinson's disease

Global molecular signature for the prognosis of hepatocellular carcinoma identified

[11C]Cimbi-36 demonstrates utility for human brain imaging

Development of Sangamo BioSciences' ZFP beta-thalassemia treatment receives support

Novel pneumonia vaccine candidate induces systemic and mucosal immune response in vivo

In vivo results for a novel ApoC-II mimetic peptide reported

Oxford BioMedica develops a novel gene therapy for IOP

A novel PET tracer shows PDE10A specificity in rat and monkey striatum

Astellas Pharma will not seek European approval for tivozanib in RCC

Valeant Pharmaceuticals to acquire Bausch & Lomb

GSK and Tempero Pharmaceuticals jointly develop HDAC9 inhibitors

Recent Merck & Co. patents describe novel ROMK blockers

Novel nicotinic alpha4beta2 receptor ligands identified by Targacept

Italian researchers synthesize novel HSP 90 inhibitors

Vertex Pharmaceuticals discloses novel Na(v)1.7 blockers

Virobay begins phase I trial of oral pain treatment candidate VBY-036

PlantForm and PharmaPraxis collaborate on biosimilars/biobetters

Astellas' isavuconazole granted orphan drug status for invasive aspergillosis

Chembio awarded U.S. government contract to develop diagnostic tests

Eisai set to launch Inovelon tablets in Japan

4SC's Japanese partner Yakult Honsha begins phase I/II study of resminostat in liver cancer

Bayer's Xarelto approved in Europe for additional indication

AstraZeneca enters definitive agreement to acquire Omthera Pharmaceuticals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...